| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |